Stay updated on ALKS 4230 in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the ALKS 4230 in Advanced Melanoma Clinical Trial page.

Latest updates to the ALKS 4230 in Advanced Melanoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe history now shows a new Revision: v3.3.3 entry and removes HHS Vulnerability Disclosure and Revision: v3.3.2 from the history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedThe page history shows a minor site revision from Revision: v3.3.1 to v3.3.2 with no changes to study data or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision: v3.3.1 was added and Revision: v3.2.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedThe funding-lapse notice about government operating status has been removed from the page, a non-critical change that does not affect trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check58 days agoChange DetectedThe latest version updates Study Status and Recruitment Status and patches in Oversight and IPDSharing sections. The record history shows the entry being returned for quality control with ongoing status updates to the trial.SummaryDifference0.1%

- Check87 days agoChange DetectedUpdate adds a government-funding status notice and NIH Clinical Center operating details with a v3.2.0 revision, while removing the old v3.1.0 tag.SummaryDifference10%

Stay in the know with updates to ALKS 4230 in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALKS 4230 in Advanced Melanoma Clinical Trial page.